164 related articles for article (PubMed ID: 31836657)
1. Overexpression of SH2-Containing Inositol Phosphatase Contributes to Chronic Lymphocytic Leukemia Survival.
Pal Singh S; de Bruijn MJW; Velaso Gago da Graça C; Corneth OBJ; Rip J; Stadhouders R; Meijers RWJ; Schurmans S; Kerr WG; Ter Burg J; Eldering E; Langerak AW; Pillai SY; Hendriks RW
J Immunol; 2020 Jan; 204(2):360-374. PubMed ID: 31836657
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells.
Lemm EA; Valle-Argos B; Smith LD; Richter J; Gebreselassie Y; Carter MJ; Karolova J; Svaton M; Helman K; Weston-Bell NJ; Karydis L; Williamson CT; Lenz G; Pettigrew J; Harwig C; Stevenson FK; Cragg M; Forconi F; Steele AJ; Cross J; Mackenzie L; Klener P; Packham G
Clin Cancer Res; 2020 Apr; 26(7):1700-1711. PubMed ID: 31831562
[TBL] [Abstract][Full Text] [Related]
3. Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency.
Pal Singh S; de Bruijn MJW; de Almeida MP; Meijers RWJ; Nitschke L; Langerak AW; Pillai SY; Stadhouders R; Hendriks RW
Front Immunol; 2018; 9():1996. PubMed ID: 30271400
[TBL] [Abstract][Full Text] [Related]
4. Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia.
Ecker V; Stumpf M; Brandmeier L; Neumayer T; Pfeuffer L; Engleitner T; Ringshausen I; Nelson N; Jücker M; Wanninger S; Zenz T; Wendtner C; Manske K; Steiger K; Rad R; Müschen M; Ruland J; Buchner M
Nat Commun; 2021 Jun; 12(1):3526. PubMed ID: 34112805
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer.
Fuhler GM; Brooks R; Toms B; Iyer S; Gengo EA; Park MY; Gumbleton M; Viernes DR; Chisholm JD; Kerr WG
Mol Med; 2012 Feb; 18(1):65-75. PubMed ID: 22033675
[TBL] [Abstract][Full Text] [Related]
6. The two SH2-domain-containing inositol 5-phosphatases SHIP1 and SHIP2 are coexpressed in human T lymphocytes.
Bruyns C; Pesesse X; Moreau C; Blero D; Erneux C
Biol Chem; 1999; 380(7-8):969-74. PubMed ID: 10494849
[TBL] [Abstract][Full Text] [Related]
7. SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.
Giuriato S; Pesesse X; Bodin S; Sasaki T; Viala C; Marion E; Penninger J; Schurmans S; Erneux C; Payrastre B
Biochem J; 2003 Nov; 376(Pt 1):199-207. PubMed ID: 12885297
[TBL] [Abstract][Full Text] [Related]
8. SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model.
Täger M; Horn S; Latuske E; Ehm P; Schaks M; Nalaskowski M; Fehse B; Fiedler W; Stocking C; Wellbrock J; Jücker M
Gene Ther; 2017 Nov; 24(11):749-753. PubMed ID: 29143813
[TBL] [Abstract][Full Text] [Related]
9. The Functional Roles of the Src Homology 2 Domain-Containing Inositol 5-Phosphatases SHIP1 and SHIP2 in the Pathogenesis of Human Diseases.
Müller SM; Jücker M
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791291
[TBL] [Abstract][Full Text] [Related]
10. Regulation of inositol 5-phosphatase activity by the C2 domain of SHIP1 and SHIP2.
Bradshaw WJ; Kennedy EC; Moreira T; Smith LA; Chalk R; Katis VL; Benesch JLP; Brennan PE; Murphy EJ; Gileadi O
Structure; 2024 Apr; 32(4):453-466.e6. PubMed ID: 38309262
[TBL] [Abstract][Full Text] [Related]
11. The SH2 domain containing inositol 5-phosphatase SHIP2 associates to the immunoreceptor tyrosine-based inhibition motif of Fc gammaRIIB in B cells under negative signaling.
Muraille E; Bruhns P; Pesesse X; Daëron M; Erneux C
Immunol Lett; 2000 Apr; 72(1):7-15. PubMed ID: 10789675
[TBL] [Abstract][Full Text] [Related]
12. Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation.
Hoekstra E; Das AM; Willemsen M; Swets M; Kuppen PJ; van der Woude CJ; Bruno MJ; Shah JP; Ten Hagen TL; Chisholm JD; Kerr WG; Peppelenbosch MP; Fuhler GM
Oncotarget; 2016 Nov; 7(45):73525-73540. PubMed ID: 27716613
[TBL] [Abstract][Full Text] [Related]
13. SHIP2 is recruited to the cell membrane upon macrophage colony-stimulating factor (M-CSF) stimulation and regulates M-CSF-induced signaling.
Wang Y; Keogh RJ; Hunter MG; Mitchell CA; Frey RS; Javaid K; Malik AB; Schurmans S; Tridandapani S; Marsh CB
J Immunol; 2004 Dec; 173(11):6820-30. PubMed ID: 15557176
[TBL] [Abstract][Full Text] [Related]
14. SH2 domain-containing inositol 5-phosphatases support the survival of Burkitt lymphoma cells by promoting energy metabolism.
Mayr F; Kruse V; Fuhrmann DC; Wolf S; Löber J; Alsouri S; Paglilla N; Lee K; Chapuy B; Brüne B; Zenz T; Häupl B; Oellerich T; Engelke M
Haematologica; 2024 May; 109(5):1445-1459. PubMed ID: 37916396
[TBL] [Abstract][Full Text] [Related]
15. Differential Lyn-dependence of the SHIP1-deficient mast cell phenotype.
Nunes de Miranda SM; Wilhelm T; Huber M; Zorn CN
Cell Commun Signal; 2016 May; 14(1):12. PubMed ID: 27206658
[TBL] [Abstract][Full Text] [Related]
16. The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia.
Wakim J; Arman E; Becker-Herman S; Kramer MP; Bakos E; Shachar I; Elson A
Oncogene; 2017 Jun; 36(26):3686-3694. PubMed ID: 28166196
[TBL] [Abstract][Full Text] [Related]
17. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
[TBL] [Abstract][Full Text] [Related]
18. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression.
Baudot AD; Jeandel PY; Mouska X; Maurer U; Tartare-Deckert S; Raynaud SD; Cassuto JP; Ticchioni M; Deckert M
Oncogene; 2009 Sep; 28(37):3261-73. PubMed ID: 19581935
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the substrate specificity of the inositol 5-phosphatase SHIP1.
Nelson N; Wundenberg T; Lin H; Rehbach C; Horn S; Windhorst S; Jücker M
Biochem Biophys Res Commun; 2020 Apr; 524(2):366-370. PubMed ID: 32005521
[TBL] [Abstract][Full Text] [Related]
20. Small molecule targeting of SHIP1 and SHIP2.
Kerr WG; Pedicone C; Dormann S; Pacherille A; Chisholm JD
Biochem Soc Trans; 2020 Feb; 48(1):291-300. PubMed ID: 32049315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]